cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5517/ccdc.csd.cc27ldkt
title: CCDC 2073266: Experimental Crystal Structure Determination

description: Related Article: Kiran Avancha, Frank R. Fronczek|2021|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc25h7pm
title: CCDC 2010650: Experimental Crystal Structure Determination

description: Related Article: Xing Guo, Bing Tang, Hao Wu, Qinghua Wu, Zeyu Xie, Changjiang Yu, Erhong Hao, Lijuan Jiao|2021|Mater. Chem. Front.|5|3664|doi:10.1039/D1QM00067E
DOI: 10.5517/ccdc.csd.cc25h7fc
title: CCDC 2010642: Experimental Crystal Structure Determination

description: Related Article: Xing Guo, Bing Tang, Hao Wu, Qinghua Wu, Zeyu Xie, Changjiang Yu, Erhong Hao, Lijuan Jiao|2021|Mater. Chem. Front.|5|3664|doi:10.1039/D1QM00067E
DOI: 10.5517/ccdc.csd.cc27ljcr
title: CCDC 2073384: Experimental Crystal Structure Determination

description: Related Article: W. Clegg, R.W. Harrington|2021|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc27ljds
title: CCDC 2073385: Experimental Crystal Structure Determination

description: Related Article: W. Clegg, R.W. Harrington|2021|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc27ljm0
title: CCDC 2073392: Experimental Crystal Structure Determination

description: Related Article: W. Clegg, R.W. Harrington|2021|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc27ljp2
title: CCDC 2073394: Experimental Crystal Structure Determination

description: Related Article: W. Clegg, R.W. Harrington|2021|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc27609s
title: CCDC 2061354: Experimental Crystal Structure Determination

description: Related Article: Nadezhda B. Tamm, Vitaliy Yu. Markov, Sergey I. Troyanov|2021|Dalton Trans.|50|5765|doi:10.1039/D1DT00493J
DOI: 10.5517/ccdc.csd.cc2760cv
title: CCDC 2061356: Experimental Crystal Structure Determination

description: Related Article: Nadezhda B. Tamm, Vitaliy Yu. Markov, Sergey I. Troyanov|2021|Dalton Trans.|50|5765|doi:10.1039/D1DT00493J
DOI: 10.5517/ccdc.csd.cc268k8b
title: CCDC 2034011: Experimental Crystal Structure Determination

description: Related Article: Sara Schmorl, Sergej Naumov, Bernd Abel, Martin Börner, Andreas Pöppl, Berthold Kersting|2021|Dalton Trans.|50|5784|doi:10.1039/D1DT00723H
DOI: 10.5517/ccdc.csd.cc27mv7z
title: CCDC 2074651: Experimental Crystal Structure Determination

description: Related Article: Eva Zahradníková, Ivana Císařová, Bohuslav Drahoš|2021|Polyhedron|203|115231|doi:10.1016/j.poly.2021.115231
DOI: 10.5517/ccdc.csd.cc27pwys
title: CCDC 2076626: Experimental Crystal Structure Determination

description: Related Article: W. Clegg, G.S. Nichol|2021|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc27pwzt
title: CCDC 2076627: Experimental Crystal Structure Determination

description: Related Article: W. Clegg, G.S. Nichol|2021|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc27px0w
title: CCDC 2076628: Experimental Crystal Structure Determination

description: Related Article: W. Clegg, G.S. Nichol|2021|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc27px1x
title: CCDC 2076629: Experimental Crystal Structure Determination

description: Related Article: W. Clegg, G.S. Nichol|2021|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc27px2y
title: CCDC 2076630: Experimental Crystal Structure Determination

description: Related Article: W. Clegg, G.S. Nichol|2021|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc27r1dg
title: CCDC 2077725: Experimental Crystal Structure Determination

description: Related Article: Peter G. Jones, Santosh Kumar Adla, Thomas Lindel|2021|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc27r1fh
title: CCDC 2077726: Experimental Crystal Structure Determination

description: Related Article: Peter G. Jones, Santosh Kumar Adla, Thomas Lindel|2021|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc27r1gj
title: CCDC 2077727: Experimental Crystal Structure Determination

description: Related Article: Peter G. Jones, Santosh Kumar Adla, Thomas Lindel|2021|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc27r1km
title: CCDC 2077730: Experimental Crystal Structure Determination

description: Related Article: Peter G. Jones, Bohdan Snovydovych, Thomas Lindel|2021|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc27r1mp
title: CCDC 2077732: Experimental Crystal Structure Determination

description: Related Article: Peter G. Jones, Alex Sudakow, Thomas Lindel|2021|CSD Communication|||
DOI: 10.5281/zenodo.4738012
title: Measurements of atmospheric radioactivity dose rates over the North Pacific after the Fukushima Daiichi nuclear power plant accident during the period March 2011 - March 2015

description: On 11 March 2011, a magnitude 9.0 earthquake occurred about 154 km northeast of the Fukushima Daiichi Nuclear Power Plant (FNPP1; $37.420^{\circ}N$ and $141.033^{\circ}E$). Here we present continuous measurements of the atmospheric dose rates after the Fukushima accident over the North Pacific atmosphere by a fleet of thirteen in-service global container cargo ships and another at a Tokyo port site from the PGGM (Pacific Greenhouse Gases Measurements) project. The continuous measurements of atmospheric dose rates were collected from a total of 294 cruises with 41,485 measurements during the period March 2011 to 2015. <br> In this work, we identify three key aspects of the impacts of the radioactive materials following the Fukushima accident: The altitude effect, the land surface effect, and the transported effect. We showed measurements of air dose rates over the land surface area and over the oceanic atmosphere. The striking differences in the air dose rates measured during the 2011-2015 period clearly identify the deposition effects and the effects associated with radioactive materials transported from the FNPP1. Air dose rates measured over the land surface areas resulted from a combination of the effects from the deposition of radioactive materials on the surface and the radioactive materials contained in the airborne particles. Air dose rates measured over the oceanic atmosphere contains radioactive effects from airborne particles. The data of air dose rates over the North Pacific atmosphere show the eastward transport of radioactivity. Eastward transport of radioactive materials had been observed after 11 Mar 2011. Monitoring data show that the export of radioactive materials to the Pacific atmosphere occurred after March 2011, and in 2012, 2013, 2014, and 2015.
description: {"references": ["Wang, K.-Y., Nedelec, P., Clark, H., and Harris, N.: Measurements of atmospheric radioactivity dose rates over the North Pacific after the Fukushima Daiichi nuclear power plant accident during the period March 2011 - March 2015, Earth System Science Data, essd-2019-156, in veriew, 2019."]}
DOI: 10.5281/zenodo.3468895
title: Measurements of atmospheric radioactivity dose rates over the North Pacific after the Fukushima Daiichi nuclear power plant accident during the period March 2011 - March 2015

description: On 11 March 2011, a magnitude 9.0 earthquake occurred about 154 km northeast of the Fukushima Daiichi Nuclear Power Plant (FNPP1; $37.420^{\circ}N$ and $141.033^{\circ}E$). Here we present continuous measurements of the atmospheric dose rates after the Fukushima accident over the North Pacific atmosphere by a fleet of thirteen in-service global container cargo ships and another at a Tokyo port site from the PGGM (Pacific Greenhouse Gases Measurements) project. The continuous measurements of atmospheric dose rates were collected from a total of 294 cruises with 41,485 measurements during the period March 2011 to 2015. <br> In this work, we identify three key aspects of the impacts of the radioactive materials following the Fukushima accident: The altitude effect, the land surface effect, and the transported effect. We showed measurements of air dose rates over the land surface area and over the oceanic atmosphere. The striking differences in the air dose rates measured during the 2011-2015 period clearly identify the deposition effects and the effects associated with radioactive materials transported from the FNPP1. Air dose rates measured over the land surface areas resulted from a combination of the effects from the deposition of radioactive materials on the surface and the radioactive materials contained in the airborne particles. Air dose rates measured over the oceanic atmosphere contains radioactive effects from airborne particles. The data of air dose rates over the North Pacific atmosphere show the eastward transport of radioactivity. Eastward transport of radioactive materials had been observed after 11 Mar 2011. Monitoring data show that the export of radioactive materials to the Pacific atmosphere occurred after March 2011, and in 2012, 2013, 2014, and 2015.
description: {"references": ["Wang, K.-Y., Nedelec, P., Clark, H., and Harris, N.: Measurements of atmospheric radioactivity dose rates over the North Pacific after the Fukushima Daiichi nuclear power plant accident during the period March 2011 - March 2015, Earth System Science Data, essd-2019-156, in veriew, 2019."]}
DOI: 10.3886/e113211v1-85800
title: Replication data for: Does Trade Cause Growth?

description: Examining the correlation between trade and income cannot identify the direction of causation between the two. Countries' geographic characteristics, however, have important effects on trade and are plausibly uncorrelated with other determinants of income. This paper, therefore, constructs measures of the geographic component of countries' trade and uses those measures to obtain instrumental variables estimates of the effect of trade on income. The results provide no evidence that ordinary least-squares estimates overstate the effects of trade. Further, they suggest that trade has a quantitatively large and robust, though only moderately statistically significant, positive effect on income.
DOI: 10.6084/m9.figshare.14535285
title: Protective effects of gingival-derived mesenchymal stem cells against LPS-induced sepsis and its complications

description: We attempted to isolate, culture, and characterize mouse gingival-derived mesenchymal stem cells (GMSCs), investigate whether GMSCs can protect against lipopolysaccharide (LPS)-induced sepsis and its complications, and related mechanisms including inflammation, oxidative stress, and the Warburg effect were explored.
DOI: 10.6084/m9.figshare.14535285.v2
title: Protective effects of gingival-derived mesenchymal stem cells against LPS-induced sepsis and its complications

description: We attempted to isolate, culture, and characterize mouse gingival-derived mesenchymal stem cells (GMSCs), investigate whether GMSCs can protect against lipopolysaccharide (LPS)-induced sepsis and its complications, and related mechanisms including inflammation, oxidative stress, and the Warburg effect were explored.
DOI: 10.6084/m9.figshare.14535285.v1
title: Protective effects of gingival-derived mesenchymal stem cells against LPS-induced sepsis and its complications

description: We attempted to isolate, culture, and characterize mouse gingival-derived mesenchymal stem cells (GMSCs), investigate whether GMSCs can protect against lipopolysaccharide (LPS)-induced sepsis and its complications, and related mechanisms including inflammation, oxidative stress, and the Warburg effect were explored.
DOI: 10.6084/m9.figshare.14538654
title: Additional file 2 of Transcriptome of different fruiting stages in the cultivated mushroom Cyclocybe aegerita suggests a complex regulation of fruiting and reveals enzymes putatively involved in fungal oxylipin biosynthesis

description: Additional file 2: Table S1. Read counts of all sequenced genes. Table S2. Genes showing a &gt; 5 fold decrease between day 22 and day 22 in the mycelium. Table S3. Genes showing a &gt; 5 fold increase between day 22 and day 22 in the mycelium.
DOI: 10.6084/m9.figshare.14538654.v1
title: Additional file 2 of Transcriptome of different fruiting stages in the cultivated mushroom Cyclocybe aegerita suggests a complex regulation of fruiting and reveals enzymes putatively involved in fungal oxylipin biosynthesis

description: Additional file 2: Table S1. Read counts of all sequenced genes. Table S2. Genes showing a &gt; 5 fold decrease between day 22 and day 22 in the mycelium. Table S3. Genes showing a &gt; 5 fold increase between day 22 and day 22 in the mycelium.
DOI: 10.6084/m9.figshare.13843555
title: Additional file 1 of Genome-wide identification of PbrbHLH family genes, and expression analysis in response to drought and cold stresses in pear (Pyrus bretschneideri)

description: Additional file 1 Table S1. Detailed characteristics of PbrbHLHs.Table S2. Duplication type of PbrbHLH genes in Chinese white pear. Table S3. Sequence informations of 20 detected motifs in MEME analysis. Table S4. The primers of PbrbHLHs for qRT-PCR and vector construction.
DOI: 10.6084/m9.figshare.13843555.v1
title: Additional file 1 of Genome-wide identification of PbrbHLH family genes, and expression analysis in response to drought and cold stresses in pear (Pyrus bretschneideri)

description: Additional file 1 Table S1. Detailed characteristics of PbrbHLHs.Table S2. Duplication type of PbrbHLH genes in Chinese white pear. Table S3. Sequence informations of 20 detected motifs in MEME analysis. Table S4. The primers of PbrbHLHs for qRT-PCR and vector construction.
DOI: 10.6084/m9.figshare.14266702
title: Additional file 31 of The migratory pathways of the cells that form the endocardium, dorsal aortae, and head vasculature in the mouse embryo

description: Additional file 31. Genes expressed in the clusters of the bottom sample Genes expressed in clusters 1–8 of the ‘bottom’ sample. Indicated per cluster are the mean of the UMI counts per gene, the Log2 fold change of the average number of reads for a given gene across cells in that cluster to that of cells not in that cluster, and the significance (p-value) of the Log2-fold change.
DOI: 10.6084/m9.figshare.14266699.v1
title: Additional file 30 of The migratory pathways of the cells that form the endocardium, dorsal aortae, and head vasculature in the mouse embryo

description: Additional file 30 Genes expressed in the clusters of the top sample Genes expressed in clusters 1–6 of the ‘top’ sample. Indicated per cluster are the mean of the UMI counts per gene, the Log2 of the fold change of the average number of reads for a given gene across cells in that cluster to that of cells not in the cluster, and the significance (p-value) of the Log2-fold change.
DOI: 10.6084/m9.figshare.14266702.v1
title: Additional file 31 of The migratory pathways of the cells that form the endocardium, dorsal aortae, and head vasculature in the mouse embryo

description: Additional file 31. Genes expressed in the clusters of the bottom sample Genes expressed in clusters 1–8 of the ‘bottom’ sample. Indicated per cluster are the mean of the UMI counts per gene, the Log2 fold change of the average number of reads for a given gene across cells in that cluster to that of cells not in that cluster, and the significance (p-value) of the Log2-fold change.
DOI: 10.6084/m9.figshare.14266699
title: Additional file 30 of The migratory pathways of the cells that form the endocardium, dorsal aortae, and head vasculature in the mouse embryo

description: Additional file 30 Genes expressed in the clusters of the top sample Genes expressed in clusters 1–6 of the ‘top’ sample. Indicated per cluster are the mean of the UMI counts per gene, the Log2 of the fold change of the average number of reads for a given gene across cells in that cluster to that of cells not in the cluster, and the significance (p-value) of the Log2-fold change.
DOI: 10.6084/m9.figshare.14266705
title: Additional file 32 of The migratory pathways of the cells that form the endocardium, dorsal aortae, and head vasculature in the mouse embryo

description: Additional file 32. Genes differentially expressed in the endoderm of top versus bottom sample Genes differentially expressed in endoderm of ‘top’ versus ‘bottom’ sample. A positive Log2-fold change indicates that the gene is upregulated in the ‘top’ sample versus the ‘bottom’ sample. A negative Log2-fold change indicates the converse.
DOI: 10.6084/m9.figshare.14266705.v1
title: Additional file 32 of The migratory pathways of the cells that form the endocardium, dorsal aortae, and head vasculature in the mouse embryo

description: Additional file 32. Genes differentially expressed in the endoderm of top versus bottom sample Genes differentially expressed in endoderm of ‘top’ versus ‘bottom’ sample. A positive Log2-fold change indicates that the gene is upregulated in the ‘top’ sample versus the ‘bottom’ sample. A negative Log2-fold change indicates the converse.
DOI: 10.6084/m9.figshare.14266714.v1
title: Additional file 35 of The migratory pathways of the cells that form the endocardium, dorsal aortae, and head vasculature in the mouse embryo

description: Additional file 35. Map of the Tal1-cerulean construct Map and full sequence of the Tal1-cerulean construct, inserted in exon 5 of the Tal1 genomic region.
DOI: 10.6084/m9.figshare.14266714
title: Additional file 35 of The migratory pathways of the cells that form the endocardium, dorsal aortae, and head vasculature in the mouse embryo

description: Additional file 35. Map of the Tal1-cerulean construct Map and full sequence of the Tal1-cerulean construct, inserted in exon 5 of the Tal1 genomic region.
DOI: 10.6084/m9.figshare.14538696
title: Additional file 1 of Initial forest age distribution may generate computational sinks or sources of carbon: A generic approach to test assumptions underlying the EU LULUCF forest reference levels

description: Additional file 1. R-code used to generate the forest age class distributions and prepare the EFDM input data.
DOI: 10.6084/m9.figshare.14538696.v1
title: Additional file 1 of Initial forest age distribution may generate computational sinks or sources of carbon: A generic approach to test assumptions underlying the EU LULUCF forest reference levels

description: Additional file 1. R-code used to generate the forest age class distributions and prepare the EFDM input data.
DOI: 10.6084/m9.figshare.14379219
title: Additional file 2 of Complex interactions of lovastatin with 10 chemotherapeutic drugs: a rigorous evaluation of synergism and antagonism

description: Additional file 2: Legends Figure S1. Schematic diagram of the 96-well plate for the dual-drug assays (see Methods). The dose-responses (Columns 9 and 10), which are required for the computation of Loewe additive synergy, are performed at the same starting concentrations and with the same dilutions as in the dual-dilution portion of the plate. The format shown is compatible with the Combenefit software. BL = Plate blank (synthetic complete media + dextrose only). Figure S2. Tamoxifen plus lovastatin data on day 3. The comparable data for day two are depicted and described in Figure 2. The synergy matrix shown here is very similar to the day two matrix. Figure S3. Doxorubicin and lovastatin interactions on day three. The data are quite similar to the results on day two, shown in Figure 3. Figure S4. Methotrexate and lovastatin on day three. The patterns are quite similar to those recorded on day two (Fig. 4). The Loewe synergy matrix (D) is the same plot as shown in Fig. 4e. Figure S5. Experimental dose-response data for the combination of rapamycin and lovastatin. The combination dose-response data are visualized as contours, with 25, 50, 75 and 100% of control levels. Even though the EC50 of rapamycin is three-fold greater on day3 (Fig. 5, d vs. a), the 25% dose-response contour is achievable at all concentrations of rapamycin with only a modest increase in lovastatin concentration compared to day two. These data, supportive of the increase in synergy seen in the Loewe matrix (Fig. 5f compared to c), suggest that lovastatin somehow prolongs the efficacy of rapamycin. Figure S6. Day three Loewe synergy matrices corresponding to the day two data shown in Fig. 6. Epothilone plus lovastatin exhibits significant synergy on day three (C) whereas the combination did not on day two (Fig. 6c). The matrix for 5-fluoruracil (A) shows no significant interactions, as it did on day two. The other four drugs, gemcitabine (B), cisplatin (D), cyclophosphamide (E), and etoposide (F), exhibit greater antagonism on the third day. Figure S7. Loewe synergy matrices on days two and three for three cell lines in dual-drug assays of cisplatin in combination with lovastatin. Two human cancer cells lines, A549 (lung adenocarcinoma) (A, D) and MCF7 (breast cancer) (C, F), exhibited significant antagonism (and no significant synergism) on day two; the antagonism was more pronounced on day three. The HT29 colon adenocarcinoma cell line exhibited synergism and antagonism, both statistically significant, on day two (B) and to a lesser degree, on day three (E). The data shown here are comparable to that obtained with the S. cerevisiae assays (see Table 2, and Figs. 6c and S6D).
DOI: 10.6084/m9.figshare.14379219.v2
title: Additional file 2 of Complex interactions of lovastatin with 10 chemotherapeutic drugs: a rigorous evaluation of synergism and antagonism

description: Additional file 2: Legends Figure S1. Schematic diagram of the 96-well plate for the dual-drug assays (see Methods). The dose-responses (Columns 9 and 10), which are required for the computation of Loewe additive synergy, are performed at the same starting concentrations and with the same dilutions as in the dual-dilution portion of the plate. The format shown is compatible with the Combenefit software. BL = Plate blank (synthetic complete media + dextrose only). Figure S2. Tamoxifen plus lovastatin data on day 3. The comparable data for day two are depicted and described in Figure 2. The synergy matrix shown here is very similar to the day two matrix. Figure S3. Doxorubicin and lovastatin interactions on day three. The data are quite similar to the results on day two, shown in Figure 3. Figure S4. Methotrexate and lovastatin on day three. The patterns are quite similar to those recorded on day two (Fig. 4). The Loewe synergy matrix (D) is the same plot as shown in Fig. 4e. Figure S5. Experimental dose-response data for the combination of rapamycin and lovastatin. The combination dose-response data are visualized as contours, with 25, 50, 75 and 100% of control levels. Even though the EC50 of rapamycin is three-fold greater on day3 (Fig. 5, d vs. a), the 25% dose-response contour is achievable at all concentrations of rapamycin with only a modest increase in lovastatin concentration compared to day two. These data, supportive of the increase in synergy seen in the Loewe matrix (Fig. 5f compared to c), suggest that lovastatin somehow prolongs the efficacy of rapamycin. Figure S6. Day three Loewe synergy matrices corresponding to the day two data shown in Fig. 6. Epothilone plus lovastatin exhibits significant synergy on day three (C) whereas the combination did not on day two (Fig. 6c). The matrix for 5-fluoruracil (A) shows no significant interactions, as it did on day two. The other four drugs, gemcitabine (B), cisplatin (D), cyclophosphamide (E), and etoposide (F), exhibit greater antagonism on the third day. Figure S7. Loewe synergy matrices on days two and three for three cell lines in dual-drug assays of cisplatin in combination with lovastatin. Two human cancer cells lines, A549 (lung adenocarcinoma) (A, D) and MCF7 (breast cancer) (C, F), exhibited significant antagonism (and no significant synergism) on day two; the antagonism was more pronounced on day three. The HT29 colon adenocarcinoma cell line exhibited synergism and antagonism, both statistically significant, on day two (B) and to a lesser degree, on day three (E). The data shown here are comparable to that obtained with the S. cerevisiae assays (see Table 2, and Figs. 6c and S6D).